BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29941295)

  • 1. Beneficial and adverse effects of antipsychotic medication on cognitive flexibility are related to COMT genotype in first episode psychosis.
    Nelson CLM; Amsbaugh HM; Reilly JL; Rosen C; Marvin RW; Ragozzino ME; Bishop JR; Sweeney JA; Hill SK
    Schizophr Res; 2018 Dec; 202():212-216. PubMed ID: 29941295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catechol-O-Methyltransferase Val158Met Polymorphism and Clinical Response to Antipsychotic Treatment in Schizophrenia and Schizo-Affective Disorder Patients: a Meta-Analysis.
    Huang E; Zai CC; Lisoway A; Maciukiewicz M; Felsky D; Tiwari AK; Bishop JR; Ikeda M; Molero P; Ortuno F; Porcelli S; Samochowiec J; Mierzejewski P; Gao S; Crespo-Facorro B; Pelayo-Terán JM; Kaur H; Kukreti R; Meltzer HY; Lieberman JA; Potkin SG; Müller DJ; Kennedy JL
    Int J Neuropsychopharmacol; 2016 May; 19(5):. PubMed ID: 26745992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catechol-O-methyltransferase genotype differentially contributes to the flexibility and stability of cognitive sets in patients with psychotic disorders and their first-degree relatives.
    Hochberger WC; Eskridge CLM; Bishop JR; Reilly JL; Rubin LH; Keedy S; Gershon ES; Tamminga CA; Pearlson GD; Ragozzino M; Keshavan MS; Sweeney JA; Hill SK
    Schizophr Res; 2020 Sep; 223():236-241. PubMed ID: 32829984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of influence of COMT Val158Met genotype on cognition in first-episode non-affective psychosis.
    Mata I; Perez-Iglesias R; Pelayo-Teran JM; Rodríguez-Sanchez JM; Gonzalez-Blanch C; Carrasco-Marin E; Vazquez-Barquero JL; Crespo-Facorro B
    Schizophr Res; 2008 Jul; 102(1-3):206-9. PubMed ID: 18407467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COMT genotype and response to cognitive remediation in schizophrenia.
    Lindenmayer JP; Khan A; Lachman H; McGurk SR; Goldring A; Thanju A; Kaushik S
    Schizophr Res; 2015 Oct; 168(1-2):279-84. PubMed ID: 26255563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COMT (Val(158/108)Met) genotype moderates the impact of antipsychotic medication on verbal IQ in twins with schizophrenia.
    Rebollo-Mesa I; Picchioni M; Shaikh M; Bramon E; Murray R; Toulopoulou T
    Psychiatr Genet; 2011 Apr; 21(2):98-105. PubMed ID: 21233783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between catechol-O-methyltransferase genetic variation and functional connectivity in patients with first-episode schizophrenia.
    Wang H; Zhang B; Zeng B; Tang Y; Zhang T; Zhao S; Li C; Wang J; Goff DC
    Schizophr Res; 2018 Sep; 199():214-220. PubMed ID: 29730044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COMT val108/158met genotype, cognitive function, and cognitive improvement with clozapine in schizophrenia.
    Woodward ND; Jayathilake K; Meltzer HY
    Schizophr Res; 2007 Feb; 90(1-3):86-96. PubMed ID: 17123785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catechol-O-methyltransferase (COMT) genotype moderates the effects of childhood trauma on cognition and symptoms in schizophrenia.
    Green MJ; Chia TY; Cairns MJ; Wu J; Tooney PA; Scott RJ; Carr VJ;
    J Psychiatr Res; 2014 Feb; 49():43-50. PubMed ID: 24252819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catechol-O-methyltransferase val108/158met genotype predicts working memory response to antipsychotic medications.
    Weickert TW; Goldberg TE; Mishara A; Apud JA; Kolachana BS; Egan MF; Weinberger DR
    Biol Psychiatry; 2004 Nov; 56(9):677-82. PubMed ID: 15522252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of COMT genotype on cognitive ability and functional capacity in individuals with schizophrenia.
    Twamley EW; Hua JP; Burton CZ; Vella L; Chinh K; Bilder RM; Kelsoe JR
    Schizophr Res; 2014 Oct; 159(1):114-7. PubMed ID: 25139113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catechol-O-methyltransferase Val158Met polymorphism and negative symptoms after acute antipsychotic treatment in first-episode non-affective psychosis.
    Pelayo-Terán JM; Pérez-Iglesias R; Vázquez-Bourgon J; Mata I; Carrasco-Marín E; Vázquez-Barquero JL; Crespo-Facorro B
    Psychiatry Res; 2011 Jan; 185(1-2):286-9. PubMed ID: 20591499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease and drug effects on internally-generated and externally-elicited responses in first episode schizophrenia and psychotic bipolar disorder.
    Keedy SK; Bishop JR; Weiden PJ; Sweeney JA; Rosen C; Marvin R; Reilly JL
    Schizophr Res; 2014 Oct; 159(1):101-6. PubMed ID: 25112158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catechol-o-methyltransferase (COMT) and proline dehydrogenase (PRODH) mRNAs in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depression.
    Tunbridge E; Burnet PW; Sodhi MS; Harrison PJ
    Synapse; 2004 Feb; 51(2):112-8. PubMed ID: 14618678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond.
    Tunbridge EM; Harrison PJ; Weinberger DR
    Biol Psychiatry; 2006 Jul; 60(2):141-51. PubMed ID: 16476412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prefrontal abnormalities, executive dysfunction and symptoms severity are modulated by COMT Val
    Rodríguez-Toscano E; Martínez K; Fraguas D; Janssen J; Pina-Camacho L; Arias B; Vieta E; Mezquida G; Amoretti S; Bernardo M; Castro-Fornieles J; Cuesta-Zorita MJ; Lobo A; González-Pinto A; Collado IC; Mané A; Arango C; Parellada M;
    Rev Psiquiatr Salud Ment (Engl Ed); 2022; 15(2):74-87. PubMed ID: 35840287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders.
    Lafuente A; Bernardo M; Mas S; Crescenti A; Aparici M; Gasso P; Deulofeu R; Mane A; Catalan R; Carne X
    Psychiatry Res; 2008 Nov; 161(2):131-41. PubMed ID: 18922583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition.
    Henquet C; Rosa A; Krabbendam L; Papiol S; Fananás L; Drukker M; Ramaekers JG; van Os J
    Neuropsychopharmacology; 2006 Dec; 31(12):2748-57. PubMed ID: 16936704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association analysis of the catechol-O-methyltransferase /methylenetetrahydrofolate reductase genes and cognition in late-onset depression.
    Wang X; Wang Z; Wu Y; Yuan Y; Hou Z; Hou G
    Psychiatry Clin Neurosci; 2014 May; 68(5):344-52. PubMed ID: 24373005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The catechol-O-methyltransferase (COMT) Val158Met genotype modulates working memory-related dorsolateral prefrontal response and performance in bipolar disorder.
    Miskowiak KW; Kjaerstad HL; Støttrup MM; Svendsen AM; Demant KM; Hoeffding LK; Werge TM; Burdick KE; Domschke K; Carvalho AF; Vieta E; Vinberg M; Kessing LV; Siebner HR; Macoveanu J
    Bipolar Disord; 2017 May; 19(3):214-224. PubMed ID: 28544426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.